Results 171 to 180 of about 51,637 (256)
Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi +4 more
wiley +1 more source
Myasthenia gravis and autoimmune overlap: Prognostic insight. [PDF]
Oguz-Akarsu E +6 more
europepmc +1 more source
Recent Progress in Double Filtration Plasmapheresis
ABSTRACT Double‐filtration plasmapheresis is an advanced extracorporeal blood purification technique that selectively removes pathogenic macromolecules based on molecular weight. Unlike conventional plasma exchange, double‐filtration plasmapheresis uses a two‐step filtration process to retain beneficial plasma components such as albumin, while ...
Dan Li +3 more
wiley +1 more source
Open-label study of efgartigimod in seronegative myasthenia gravis. [PDF]
Khateb M +8 more
europepmc +1 more source
AIRE's Complex Role Beyond Promiscuous Gene Expression
ABSTRACT Central tolerance, established in the thymus, ensures T cells are nonreactive to self‐antigens while maintaining a functional immune repertoire. Medullary thymic epithelial cells (mTECs) and thymic dendritic cells (DCs) play a crucial role in this mechanism by orchestrating the selection and deletion of autoreactive thymocytes, a process ...
Pärt Peterson
wiley +1 more source
Comparison of the Quantitative Myasthenia Gravis and Myasthenia Gravis Activity of Daily Living Scores From a Clinical Practice Perspective. [PDF]
Wu W, Petersson M, Piehl F, Brauner S.
europepmc +1 more source
Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk +8 more
wiley +1 more source
FcRn inhibitors for myasthenia gravis. [PDF]
White LM +8 more
europepmc +1 more source
Myasthenia gravis and Schmidt syndrome [PDF]
J. K. McAlpine, J.E. Thomson
openalex +1 more source

